Dacilon 0.5 mg Injection belongs to the group of medicines called antibiotics indicated in the treatment of Wilms' tumour (kidney cancer), rhabdomyosarcoma (muscle cancer), Ewing's sarcoma (bone cancer), melanoma (skin cancer), and cancer of the uterus and testis.

Dacilon 0.5 mg Injection contains Dactinomycin, which works by slowing or stopping the growth of cancer cells. It prevents the reproduction of abnormal cells associated with cancer. Thereby, it helps treat cancer.

In some cases, Dacilon 0.5 mg Injection may cause side effects such as nausea, vomiting, fatigue, diarrhoea, stomach pain, and fever. Most of these side effects may not require medical attention and resolve over time. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.

Let the doctor know if you are allergic to any components in Dacilon 0.5 mg Injection. Dacilon 0.5 mg Injection is not recommended during pregnancy and breastfeeding. Keep your doctor informed about your health condition and medications to rule out any side effects/interactions.

Dacilon 0.5 mg Injection is used in the treatment of Wilm’s tumour (kidney cancer), rhabdomyosarcoma (muscle cancer), Ewing’s sarcoma (bone cancer), melanoma (skin cancer), testicular cancer and gestational trophoblastic tumours (cancer of the uterus). The detailed uses of Dacilon 0.5 mg Injection are as follows:

• Treat Wilm’s tumor: Dacilon 0.5 mg Injection is part of combination chemotherapy for this kidney cancer primarily affecting children, helping inhibit tumor growth and prevent recurrence.
• Manage rhabdomyosarcoma: Dacilon 0.5 mg Injection is used to treat soft tissue cancers in children by interfering with cancer cell replication and enhancing the effects of other chemotherapeutic agents.
• Treat Ewing’s sarcoma: Dacilon 0.5 mg Injection is included in multi-phase chemotherapy regimens for this bone and soft tissue cancer, improving survival outcomes.
• Address metastatic non-seminomatous testicular cancer: Dacilon 0.5 mg Injection helps reduce tumor burden and control disease progression when used with other cytotoxic drugs.
• Treat gestational trophoblastic neoplasia: Dacilon 0.5 mg Injection is effective in managing tumors arising from placental tissue, including choriocarcinoma, by halting abnormal cell proliferation.

• Follow your doctor’s instructions on the dosage and timing of this medication, to improve effectiveness.
• Dacilon 0.5 mg Injection will be administered by a healthcare professional.
• Do not self-administer it.

Dacilon 0.5 mg Injection belongs to the group of medicines called antibiotics indicated in the treatment of Wilms' tumour (kidney cancer), rhabdomyosarcoma (muscle cancer), Ewing's sarcoma (bone cancer), melanoma (skin cancer), testicular cancer, and gestational trophoblastic tumours (a type of tumour that forms inside a woman's uterus while she is pregnant). Dacilon 0.5 mg Injection contains Dactinomycin, which works by slowing or stopping the growth of cancer cells. It prevents the reproduction of abnormal cells associated with cancer. Thereby, it helps treat cancer.

Do not use Dacilon 0.5 mg Injection if you are allergic to any of its components if you have chickenpox or shingles, or if you are pregnant or breastfeeding. Consult the doctor immediately if you become pregnant during treatment with Dacilon 0.5 mg Injection. Inform the doctor if you have/had bone marrow problems, liver or kidney problems, if you are undergoing radiation therapy or if you have received X-ray treatment. Seek medical attention if you experience pain, itching, redness, blisters, swelling, or sores at the site of injection. Let the doctor know if you are taking any other medicines, including supplements or herbal products.